Search

everythinglearnresearchcommunity

for

Search:↓

Some hair proteins are specific to hair, while others are also found in skin cells.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Ostrich antibodies can help restore hair growth in people with a specific type of hair loss, increasing hair count by 71% on average.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Mogamulizumab can cause hair loss and skin rashes.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

ILC1-like cells can independently cause alopecia areata.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Human hair contains a substance that shows blood group A activity.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Certain immune markers and vitamin levels could help diagnose alopecia areata.